Summary
Medicinal chemistry requires more efficient and diverse methods for the asymmetric synthesis of chiral scaffolds. Over 60% of the world’s top selling small molecule drug compounds are chiral and, of these, approximately 80% are marketed as single enantiomers. There is a...
More information & hyperlinks
| Web resources: | https://bowerresearchgroup.wordpress.com/ |